MedTrace Logo

Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions

NCT01574664 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-05-21

No results posted yet for this study

Summary

The goal of this investigation is to obtain clinical data to show the Health Beacons Radiofrequency Identification (RFID) Localization System is safe and performs as intended as a localization device for marking and retrieving a non-palpable surgical target from the breast.

Conditions

  • Non-palpable Breast Lesions

Interventions

DEVICE

RFID Tag (Health Beacon)

The radiologist or surgeon will place the Health Beacons RFID Tag under ultrasonic or stereotactic guidance. The surgeon will use the Tagfinder to locate the lesion.

Sponsors & Collaborators

  • Health Beacons

    lead INDUSTRY

Principal Investigators

  • Murray Reicher, MD · Health Beacons

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2017-03-31
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01574664 on ClinicalTrials.gov